Michele Guida

7PUBLICATIONS
42CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsNeural networksCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 04, 2026
Circulating thymidine kinase activity predicts survival and optimal treatment sequencing in BRAF-mutated metastatic melanoma in the SECOMBIT trial.

|May 04, 2026
Discontinuation of combo immunotherapy and outcome of patients with melanoma brain metastases.

|Aug 12, 2025
Phase II study of retifanlimab in patients with recurrent locally advanced or metastatic Merkel cell carcinoma (POD1UM-201).

Giovanni Grignani, Piotr Rutkowski, Céleste Lebbé

|Sep 12, 2024
An artificial intelligence-based model exploiting H&E images to predict recurrence in negative sentinel lymph-node melanoma patients.

Maria Colomba Comes, Livia Fucci, Sabino Strippoli

|Jun 11, 2021
Primary Analysis and 4-Year Follow-Up of the Phase III NIBIT-M2 Trial in Melanoma Patients With Brain Metastases.

Anna Maria Di Giacomo, Vanna Chiarion-Sileni, Michele Del Vecchio

|Mar 06, 2021
Examining the Relationship between Circulating CD4- CD8- Double-Negative T Cells and Outcomes of Immuno-Checkpoint Inhibitor Therapy-Looking for Biomarkers and Therapeutic Targets in Metastatic Melanoma.

Sabino Strippoli, Annarita Fanizzi, Antonio Negri

Pageof 2

Frequent Collaborators

2 joint publications

Vanna Chiarion-Sileni

2 joint publications

Paolo A Ascierto

2 joint publications

Ana Arance

2 joint publications

Reinhard Dummer